VIRALGEN

The 2L feasibility study we offer at Viralgen is an important step in enabling our customers to make data-driven decisions about working with us and the needs of their programs, without requiring a long-term commitment... Viralgen's mission is to support its clients from development to the commercial manufacture of gene therapy drugs to ensure they obtain therapeutics of the highest quality, at the right time and at the right scale to meet the needs of their patients worldwide... The company's aspiration - to provide access to curative medicines to people with genetic diseases - is only achieved when Viralgen understands the personal and professional needs of patients, our employees, customers, suppliers, investors and society.

Primary location: San Sebastián Spain